Clinical Trials Logo

Filter by:
NCT ID: NCT04668833 Active, not recruiting - Clinical trials for Solid Tumor Malignancies

ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter

Start date: September 29, 2020
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to learn if giving autologous lymphocyte infusions to patients who are receiving chemotherapy and radiation for non-small cell lung cancer or esophageal cancer is safe and effective.

NCT ID: NCT04668599 Active, not recruiting - Heart Failure Clinical Trials

Cardio-pulmonary Rehabilitation and Sleep Quality

Start date: May 11, 2020
Phase:
Study type: Observational

In this prospective cohort study the investigators aim to evaluate the effect of pulmonary rehabilitation on sleep quality. Disturbed sleep is associated with, frequent exacerbations, increase in the severity of disease and increased mortality in chronic obstructive pulmonary disease (COPD). Sleep quality is a good predictor of quality of life in patients with stable COPD. However, there has been little investigation into non-pharmacological methods to improve sleep quality in patients with COPD and heart failure. It is also uncertain, how long the beneficial effects of cardio-pulmonary rehabilitation on sleep quality, if any, usually last. Due to lack of robust data, the investigators sought to find the effect of cardio-pulmonary rehabilitation on sleep quality.

NCT ID: NCT04668001 Active, not recruiting - Down Syndrome Clinical Trials

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

TransPhoM-DS
Start date: October 19, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to better understand the effects of transcranial photobiomodulation (tPBM) on neural oscillations of individuals diagnosed with Down syndrome.

NCT ID: NCT04667572 Active, not recruiting - Keratoconus Clinical Trials

Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Start date: February 1, 2021
Phase: Phase 1
Study type: Interventional

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions

NCT ID: NCT04667507 Active, not recruiting - Pharmacokinetics Clinical Trials

Pharmacokinetics of Aqueous Dexamethasone

Start date: January 1, 2021
Phase: Phase 4
Study type: Interventional

The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.

NCT ID: NCT04667416 Active, not recruiting - Clinical trials for Chronic Ulcer of Lower Extremity

Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities

Start date: January 19, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and preliminary efficacy of PalinGen® Flow for the treatment of chronic ulcers of the lower legs and feet.

NCT ID: NCT04667247 Active, not recruiting - COVID-19 Clinical Trials

Mushroom-based Product for COVID-19

MACH19
Start date: December 3, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), to treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to self-quarantined and home management. The study aims to establish the safety and feasibility of the use of FoTv vs placebo in 66 total subjects.

NCT ID: NCT04666649 Active, not recruiting - Clinical trials for Relapsed or Refractory Acute Myeloid Leukemia

Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Start date: March 10, 2021
Phase: Phase 1
Study type: Interventional

Evaluate the safety and tolerability of pegcrisantaspase in combination with venetoclax (Ven-PegC) and estimate the maximum tolerated doses and/or biologically active doses of Ven-PegC in patients with relapsed or refractory acute myeloid leukemia (R/R AML)

NCT ID: NCT04666259 Active, not recruiting - Clinical trials for Chronic Myelogenous Leukemia - Chronic Phase

Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

AIM4CML
Start date: May 25, 2021
Phase: Phase 3
Study type: Interventional

This study will be a multicenter Phase IIIb open-label, three-cohort study of asciminib in patients with CML-CP without T315I mutation who have had at least 2 prior TKIs and CML-CP harboring the T315I mutation with at least 1 prior TKI

NCT ID: NCT04666129 Active, not recruiting - Clinical trials for Metastatic Castration-Resistant Prostate Cancer

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Start date: February 18, 2021
Phase: Phase 1
Study type: Interventional

This study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a 12-week treatment period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate cancer (mCSPC) or non-metastatic or metastatic castration-resistant prostate cancer (nmCRPC or mCRPC).